Results 241 to 250 of about 381,364 (391)
Abstract Objective To investigate disparities in the utilization of genetic sequencing among children with Infantile Epileptic Spasms Syndrome (IESS), a severe early‐onset epilepsy where timely diagnosis and treatment are crucial for improving neurodevelopmental outcomes, previous studies have highlighted disparities in the evaluation and management of
Kenza El Marzouki+10 more
wiley +1 more source
Low‐field MRI: Clinical promise and challenges
Modern MRI scanners have trended toward higher field strengths to maximize signal and resolution while minimizing scan time. However, high‐field devices remain expensive to install and operate, making them scarce outside of high‐income countries and major population centers.
Thomas Campbell Arnold+3 more
wiley +1 more source
Smartphone-based Stroop Test, EncephalApp: What is the optimal cutoff for diagnosing minimal hepatic encephalopathy? [PDF]
Masuzaki R, Kogure H.
europepmc +1 more source
Experimental Acute Lead Encephalopathy in the Juvenile Rhesus Monkey [PDF]
Raymond A. Clasen+5 more
openalex +1 more source
Abstract This is a letter to the editor commenting on a recently published study on electrographic seizures as predictors of epilepsy in neonates with encephalopathy. The letter highlights potential overemphasis on electrographic neonatal seizures, underscores the importance of severely abnormal EEG backgrounds and advanced neuroimaging, and suggests ...
Lucia Fusco
wiley +1 more source
Case report: post COVID-19 encephalopathy and oral cenesthopathy. [PDF]
Wu JI, Lee SH, Chen PJ.
europepmc +1 more source
Dermatomyositis-Related Encephalopathy: Clinical, Neuroimaging and Immunological Characterization. [PDF]
Carrillo-Vázquez DA+10 more
europepmc +1 more source
A method for serum octanoate in hepatic cirrhosis and hepatic encephalopathy. [PDF]
Joseph L. Rabinowitz+7 more
openalex +1 more source
Abstract Objective To report interim data from an ongoing, open‐label extension (OLE) of a Phase 2b study (X‐TOLE) of azetukalner in adults with focal onset seizures (FOS) receiving 1–3 antiseizure medications. Methods Eligible participants enrolled in the 7‐year OLE at 20 mg azetukalner once daily with food.
Jacqueline A. French+62 more
wiley +1 more source